Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

944 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer.
Barra F, Evangelisti G, Ferro Desideri L, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Barra F, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2019 Feb;28(2):131-142. doi: 10.1080/13543784.2018.1558202. Epub 2018 Dec 21. Expert Opin Investig Drugs. 2019. PMID: 30574817 Review.
Pemetrexed disodium in ovarian cancer treatment.
Morotti M, Valenzano Menada M, Venturini PL, Mammoliti S, Ferrero S. Morotti M, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2012 Apr;21(4):437-49. doi: 10.1517/13543784.2012.661714. Epub 2012 Feb 13. Expert Opin Investig Drugs. 2012. PMID: 22324304 Review.
Bevacizumab in endometrial cancer treatment.
Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Morotti M, et al. Among authors: ferrero s. Expert Opin Biol Ther. 2012 May;12(5):649-58. doi: 10.1517/14712598.2012.672558. Epub 2012 Mar 20. Expert Opin Biol Ther. 2012. PMID: 22428875
Monoclonal antibodies therapies for ovarian cancer.
Leone Roberti Maggiore U, Bellati F, Ruscito I, Gasparri ML, Alessandri F, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Biol Ther. 2013 May;13(5):739-64. doi: 10.1517/14712598.2013.767328. Epub 2013 Feb 4. Expert Opin Biol Ther. 2013. PMID: 23373587 Review.
Sorafenib for ovarian cancer.
Leone Roberti Maggiore U, Valenzano Menada M, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2013 Aug;22(8):1049-62. doi: 10.1517/13543784.2013.802769. Epub 2013 May 15. Expert Opin Investig Drugs. 2013. PMID: 23675696 Review.
Targeting tyrosine-kinases in ovarian cancer.
Morotti M, Becker CM, Menada MV, Ferrero S. Morotti M, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2013 Oct;22(10):1265-79. doi: 10.1517/13543784.2013.816282. Epub 2013 Jul 2. Expert Opin Investig Drugs. 2013. PMID: 23815710 Review.
The potential of sunitinib as a therapy in ovarian cancer.
Leone Roberti Maggiore U, Valenzano Menada M, Venturini PL, Ferrero S. Leone Roberti Maggiore U, et al. Among authors: ferrero s. Expert Opin Investig Drugs. 2013 Dec;22(12):1671-86. doi: 10.1517/13543784.2013.841138. Epub 2013 Sep 26. Expert Opin Investig Drugs. 2013. PMID: 24070205 Review.
Current opinion on bevacizumab on endometrial cancer treatment.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: ferrero s. Expert Opin Biol Ther. 2015 Feb;15(2):299-307. doi: 10.1517/14712598.2015.995624. Epub 2014 Dec 24. Expert Opin Biol Ther. 2015. PMID: 25539414
944 results